NCT06433336

Brief Summary

Effect of blood pressure on cardiovascular outcomes and recurrence after catheter ablation in patients with atrial fibrillation

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
800

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2019

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2019

Completed
5.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 21, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 21, 2024

Completed
1 day until next milestone

First Submitted

Initial submission to the registry

May 22, 2024

Completed
7 days until next milestone

First Posted

Study publicly available on registry

May 29, 2024

Completed
Last Updated

May 29, 2024

Status Verified

May 1, 2024

Enrollment Period

5.4 years

First QC Date

May 22, 2024

Last Update Submit

May 22, 2024

Conditions

Atrial Fibrillation, PersistentBlood Pressure

Outcome Measures

Primary Outcomes (1)

  • cardiovascular events

    death AMI stroke

    1 years

Study Arms (1)

Effect of blood pressure on cardiovascular outcomes and recurrence after catheter ablation in patien

Atrial Fibrillation Recurrence Pulmonary Vein Isolation

Eligibility Criteria

Sexall
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Between February 2019 and December 2024, 800 consecutive patients who had been referred to lanzhou University second Hospital for treatment of AF and underwent successful ablation were assessed

You may not qualify if:

  • No follow-up

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Lanzhou University Second Hospital

Lanzhou, Gansu, 730030, China

Location

MeSH Terms

Conditions

Atrial Fibrillation

Condition Hierarchy (Ancestors)

Arrhythmias, CardiacHeart DiseasesCardiovascular DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • xiao wei xiaowei zhang, PHD

    Lanzhou University Second Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
1 Year
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
lanzhou university second hospital

Study Record Dates

First Submitted

May 22, 2024

First Posted

May 29, 2024

Study Start

January 1, 2019

Primary Completion

May 21, 2024

Study Completion

May 21, 2024

Last Updated

May 29, 2024

Record last verified: 2024-05

Locations

CN(1)